Molecular pathologic characteristics and therapeutic strategy for triple negative breast cancer张清媛865-869
Relationship between ERCC5 promoter polymorphism and chemosensitivity of oxaliplatin-based chemotherapy in patients with advanced colorectal cancer陈建芳, 梁后杰, 王东, 童晶涛, 廖玲870-874
Effect of transferred c-met antisense gene on vascular endothelial growth factor of human ovarian cancer cell line SKOV3王化丽, 战芳, 朱晓钰875-878
Influence of STAT5 siRNA on HeLa cell proliferation and apoptosis and its molecular mechanism段钊, 主改侠, 薛翔, 张欣879-883
Relationship between expression of βⅢ-tubulin, stathmin and drug resistance to paclitaxel in local advanced non-small cell lung cancer杨俊泉, 汪宏斌, 刘宏侠884-889
Expression of survivin, caspase-3 in glioma and its relationship with cell apoptosis康俊龙, 田新华, 张俊卿890-894
Expression and significance of EGFR and VEGF in colorectal carcinoma魏晓莹, 孙新臣, 曹远东, 方明治, 成红艳, 赵迪, 李瑞平, 王国庆895-899
Experimental research on advanced lung cancer cachexia model with Benefiting qi clearing heat and nourishing yin Decoction杜秀平, 韩正祥, 高向阳, 史会昌900-903
Prognostic significance of changes in serum levels of CEA during first-line, conventional chemotherapy in patients with advanced non-small cell lung cancer钱倩, 宋勇, 展平, 魏淑珍904-907
Prognostic factors of patients with non-small cell lung cancer: A retrospective analysis of 1 560 cases蒋峰, 胡振东, 冯冬杰, 张治, 陆建伟, 史美祺, 冯平柏, 许林908-911
